Navigation Links
Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
Date:4/4/2008

ANN ARBOR, Mich., April 4, 2008 /PRNewswire/ -- Terumo Cardiovascular Systems (Terumo CVS) announced yesterday that it is responding to a patent infringement complaint by Maquet Cardiovascular LLC. The complaint alleges that Terumo CVS and its parent company, Terumo Corporation, had infringed on two patents related to the sale of the Terumo(R) VirtuoSaph(TM) Endoscopic Vein Harvesting System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )

Terumo CVS states that its policy and its practice are not to infringe on the valid intellectual property rights of any company. The VirtuoSaph system is protected by multiple Terumo patents.

"Frankly, we're surprised at this lawsuit as these patents are several years old and our product has been on the market for more than three years with great success," says Mark DiClemente, Vice President, Sales, Terumo Cardiovascular Systems. "Our competitor has only recently entered the vessel harvesting market through an acquisition."

Terumo CVS has sold the VirtuoSaph system in the United States since January 2005. The product is also distributed in Japan and Asia by Terumo Corporation and in Europe by Terumo's European subsidiary.

The VirtuoSaph system is used during coronary artery bypass grafting (CABG), the most common cardiac surgery procedure. During the procedure, the surgeon removes a healthy artery or vein from elsewhere in the body, most often the saphenous vein in the leg, and uses it to route blood around a blockage in a coronary artery. The VirtuoSaph system allows the surgical team to remove the saphenous vein using very small incisions. Endoscopic procedures have been shown to minimize scarring, morbidity and infection associated with traditional longitudinal incisions.

Terumo Cardiovascular Systems Corporation manufactures and markets medical devices for the global cardiac surgery and interventional markets. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and Tustin, California. It is one of several subsidiaries of Terumo Corporation of Japan focused exclusively on the cardiac and vascular markets, including Terumo Heart Inc., developer of a ventricular assist device. For more information, visit http://www.terumo-cvs.com.

Terumo Corporation is a premier global medical device company with annual sales in excess of 270,000 (million) yen for the year ending March 31, 2007. Founded in 1921, the company develops, manufactures and distributes world- class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products.


'/>"/>
SOURCE Terumo Cardiovascular Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
2. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
3. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
4. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
5. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
6. Pot bellies linked to early signs of cardiovascular disease
7. Air pollution linked to cardiovascular risk indices in healthy young adults
8. Environmental stress probed in cardiovascular disease, diabetes
9. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
10. American Heart Association Enhances eLearning for Emergency Cardiovascular Care (ECC)
11. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
Breaking Medicine Technology: